Kildal Wanja, Risberg Björn, Abeler Vera M, Kristensen Gunnar B, Sudbø Jon, Nesland Jahn M, Danielsen Håvard E
Department of Medical Informatics, The Norwegian Radium Hospital, 0310 Oslo, Norway.
Eur J Cancer. 2005 May;41(8):1127-34. doi: 10.1016/j.ejca.2005.01.022. Epub 2005 Apr 14.
The CTNNB1 gene and its product beta-catenin, a regulator of the Wnt signalling pathway, is often mutated and deregulated in human malignancies. Down stream targets of the Wnt signalling pathway are linked to genomic instability. In this study, the impact of beta-catenin expression on genomic instability in ovarian carcinoma, as determined by DNA ploidy, was investigated. Expression of beta-catenin was examined by immunohistochemistry in 253 ovarian carcinomas. The results were related to genomic instability and clinicopathological features of the patients. Membrane associated staining of beta-catenin was detected in nearly all cases with no correlation to clinical parameters. Most of the samples also had cytoplasmic (84%), while only 13% had nuclear beta-catenin localisation. A significant association between beta-catenin expression (cytoplasmic and nuclear) and histological subtype and degree of differentiation was observed. Nuclear beta-catenin was almost exclusively present in endometroid carcinomas. 53% of all endometroid tumours were positive for nuclear beta-catenin expression (P<0.0001). Mucinous carcinomas had the highest degree of cytoplasmic beta-catenin expression (92%), followed by endometroid (92%), mixed (90%), serous (82%), unclassified adenocarcinomas (81%), carcinomas clear cell and (70%), (P=0.01). Tumours with differentiation grade 1 (16%) and 2 (24%) had higher nuclear beta-catenin expression than grade 3 and clear cell carcinomas (6%) (P=0.012). Better prognostic outcome was found for patients with nuclear beta-catenin localisation as compared to the cases without (P=0.027). In conclusion, the study showed no correlation between beta-catenin expression in ovarian carcinoma and FIGO stage and genomic instability as determined by DNA ploidy status. However, nuclear beta-catenin expression was strongly associated with endometroid histological subtype. Finally, in ovarian cancer, although beta-catenin staining seems to be of prognostic importance with respect to nuclear staining in univariate analysis, only DNA ploidy status, histological grade and FIGO staging were of independent prognostic significance in multivariate analysis.
CTNNB1基因及其产物β-连环蛋白是Wnt信号通路的一种调节因子,在人类恶性肿瘤中常发生突变并失调。Wnt信号通路的下游靶点与基因组不稳定性有关。在本研究中,研究了通过DNA倍性确定的β-连环蛋白表达对卵巢癌基因组不稳定性的影响。采用免疫组织化学方法检测了253例卵巢癌中β-连环蛋白的表达。结果与患者的基因组不稳定性和临床病理特征相关。几乎所有病例均检测到β-连环蛋白的膜相关染色,且与临床参数无关。大多数样本也有细胞质染色(84%),而只有13%有细胞核β-连环蛋白定位。观察到β-连环蛋白表达(细胞质和细胞核)与组织学亚型和分化程度之间存在显著关联。细胞核β-连环蛋白几乎仅存在于子宫内膜样癌中。所有子宫内膜样肿瘤中有53%的细胞核β-连环蛋白表达呈阳性(P<0.0001)。黏液性癌的细胞质β-连环蛋白表达程度最高(92%),其次是子宫内膜样癌(92%)、混合性癌(90%)、浆液性癌(82%)、未分类腺癌(81%)、透明细胞癌(70%)(P=0.01)。1级(16%)和2级(24%)分化的肿瘤细胞核β-连环蛋白表达高于3级和透明细胞癌(6%)(P=0.012)。与无细胞核β-连环蛋白定位的患者相比,有细胞核β-连环蛋白定位的患者预后更好(P=0.027)。总之,该研究表明卵巢癌中β-连环蛋白表达与国际妇产科联盟(FIGO)分期以及通过DNA倍性状态确定的基因组不稳定性之间无相关性。然而,细胞核β-连环蛋白表达与子宫内膜样组织学亚型密切相关。最后,在卵巢癌中,虽然在单因素分析中β-连环蛋白染色似乎对细胞核染色具有预后意义,但在多因素分析中只有DNA倍性状态、组织学分级和FIGO分期具有独立的预后意义。